肝纤维化无创性综合指标诊断模型的研究进展

陈茂伟; 吴继周

肝纤维化无创性综合指标诊断模型的研究进展

广西医科大学第一附属医院感染性疾病科

基金项目:

广西科学基金项目(桂科青0832033)；广西医科大学博士启动基金项目(308050)；

详细信息

中图分类号: R575.2
计量
- 文章访问数: 3066
- HTML全文浏览量: 3
- PDF下载量: 1160
- 被引次数: 0
出版历程
- 出版日期: 2009-06-20

Research funding:

摘要

HTML全文

参考文献(27)

[1]Poynard T, Aubert A, Bedossa P, et al.A simple biological index for detection of alcoholic liver disease in drinkers[J].Gastroenterolo-gy, 1991, 100 (5Pt1) ∶1397-402.

[2]Naveau S, Poynard T, Benattar C, et al.Alpha-2-macroglobulin and hepatic fibrosis.Diagnostic interest[J].Dig Dis Sci, 1994, 39 (11) ∶2426-32.

[3]张文胜, 王宝恩, 王泰龄, 等.慢性乙型肝炎肝纤维化无创性诊断模型的建立[J].中华肝脏病杂志2006, 14 (3) ∶169-173.

[4]Patel K, Gordon SC, Jacobson I, et al.Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients[J].J Hepatol, 2004, 41 (6) ∶935-42.

[5]Zaman A, Rosen HR, Ingram K, et al.Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients[J].Am J Med, 2007, 120 (3) ∶280e9-14.

[6]Rosenberg WM, Voelker M, Thiel R, et al.Serum markers detect the presence of liver fibrosis:a cohort study[J].Gastroenterology, 2004, 127 (6) ∶1704-13.

[7]Kelleher TB, Mehta SH, Bhaskar R, et al.Prediction of hepatic fi-brosis in HIV/HCV co-infected patients using serum fibrosis mark-ers:the SHASTA index[J].J Hepatol, 2005, 43 (1) ∶78-84.

[8]Zeng MD, Lu LG, Mao YM, et al.Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninva-sive model[J].Hepatology, 2005, 42 (6) ∶1437-45.

[9]Cales P, Oberti F, Michalak S, et al.A novel panel of blood mark-ers to assess the degree of liver fibrosis[J].Hepatology, 2005, 42 (6) ∶1373-81.

[10]Adams LA, Bulsara M, Rossi E, et al.Hepascore:an accurate validated predictor of liver fibrosis in chronic hepatitis C infection[J].Clin Chem, 2005, 51 (10) ∶1867-73.

[11]Imbert-Bismut F, Ratziu V, Pieroni L, et al.Biochemical mark-ers of liver fibrosis in patients with hepatitis C virus infection:a pro-spective study[J].Lancet, 2001, 357 (9262) ∶1069-75.

[12]Poynard T, Morra R, Halfon P, et al.Meta-analyses of FibroTest diagnostic value in chronic liver disease[J].BMC Gastroenterol, 2007, 7∶40.

[13]Forns X, Ampurdanes S, Llovet JM, et al.Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model[J].Hepatology, 2002, 36 (4Pt1) ∶986-92.

[14]Wai CT, Greenson JK, Fontana RJ, et al.Asimple noninvasive in-dex can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C[J].Hepatology, 2003, 38 (2) ∶518-26.

[15]Sud A, Hui JM, Farrell GC, et al.Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a proba-bility index[J].Hepatology, 2004, 39 (5) ∶1239-47.

[16]Islam S, Antonsson L, Westin J, et al.Cirrhosis in hepatitis C vi-rus-infected patients can be excluded using an index of standard bi-ochemical serum markers[J].Scand J Gastroenterol, 2005, 40 (7) ∶867-72.

[17]Westin J, Ydreborg M, Islam S, et al.A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infection[J].Scand J Gastroenterol, 2008, 43 (1) ∶73-80.

[18]Hui AY, Chan HL, Wong VW, et al.Identification of chronic hep-atitis B patients without significant liver fibrosis by a simple noninva-sive predictive model[J].Am J Gastroenterol, 2005, 100 (3) ∶616-23.

[19]Kim BK, Kim SA, Park YN, et al.Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B[J].Liver Int, 2007, 27 (7) ∶969-76.

[20]周琨, 郑瑞丹, 咸建春, 等.从常规指标中建立肝纤维化非创伤性诊断模型[J].肝脏, 2008, 13 (5) ∶362-367.

[21]Bonacini M, Hadi G, Govindarajan S, et al.Utility of a discrimi-nant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection[J].Am J Gastroenterol, 1997, 92 (8) ∶1302-4.

[22]Poynard T, Bedossa P.Age and platelet count:a simple index for predicting the presence of histological lesions in patients with antibod-ies to hepatitis C virus.METAVIR and CLINIVIR Cooperative Study Groups[J].J Viral Hepat, 1997, 4 (3) ∶199-208.

[23]Giannini E, Risso D, Botta F, et al.Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in as-sessing disease severity and prognosis in patients with hepatitis C vi-rus-related chronic liver disease[J].Arch Intern Med, 2003, 163 (2) ∶218-24.

[24]Pohl A, Behling C, Oliver D, et al.Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepa-titis C virus infection[J].Am J Gastroenterol, 2001, 96 (11) ∶3142-6.

[25]夏琦, 符节海, 蔡卫民, 等.AST/PLT和GGT/PLT比值对肝纤维化的诊断价值[J].临床肝胆病杂志, 2007, 23 (6) ∶364-366.

[26]Sebastiani G, Vario A, Guido M, et al.Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases[J].J Viral Hepat, 2008, 15 (3) ∶212-8.

[27]Bourliere M, Penaranda G, Ouzan D, et al.Optimized stepwise combination algorithms of non-invasive liver fibrosis scores inclu-ding Hepascore in hepatitis C virus patients[J].Aliment Pharmacol Ther, 2008, 28 (4) ∶458-67.

施引文献

资源附件(0)

访问统计